Standard Biotools (LAB) Other Accumulated Expenses (2022 - 2026)

Standard Biotools (LAB) has 5 years of Other Accumulated Expenses data on file, last reported at $1.5 million in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 66.99% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 66.99% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 68.85% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $1.5 million, up from $1.5 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for LAB reached as high as $7.3 million in Q3 2024 and fell as low as $714000.0 in Q3 2023.
• Historically, Other Accumulated Expenses has averaged $3.5 million across 5 years, with a median of $3.3 million in 2023.
• Across the five-year window, Other Accumulated Expenses jumped 917.51% in 2024 and slumped 83.63% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $913000.0 in 2022, then surged by 341.73% to $4.0 million in 2023, then gained by 15.5% to $4.7 million in 2024, then tumbled by 68.85% to $1.5 million in 2025, then grew by 5.79% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $2.5 million in Q3 2025.